Salvo Health Revolutionizes GI Care with $5M Funding

Salvo Health, a NYC-based healthcare tech company, secures $5M in Seed Prime funding to expand its innovative "wraparound care" model for chronic gastrointestinal and metabolic liver conditions. Led by City Light Capital and Human Ventures, the funding will fuel nationwide deployment of Salvo's unique approach, empowering local providers and improving patient outcomes. Joining the Board of Directors are healthcare innovation experts Rachel Parlier and Emily Melton, signaling a bright future for Salvo's impactful mission.